Sone Hirohito, Shimano Hitoshi, Shu Miao, Nakakuki Masanori, Takahashi Akimitsu, Sakai Masakazu, Sakamoto Yuichiro, Yokoo Tomotaka, Matsuzaka Ken, Okazaki Hiroaki, Nakagawa Yoshimi, Iida Kaoruko Tada, Suzuki Hiroaki, Toyoshima Hideo, Horiuchi Seikoh, Yamada Nobuhiro
Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.
Biochem Biophys Res Commun. 2004 Apr 9;316(3):790-4. doi: 10.1016/j.bbrc.2004.02.121.
The ATP-binding-cassette transporter A1 (ABCA1) plays an essential role in cellular cholesterol efflux and helps prevent macrophages from becoming foam cells. The statins are widely used as cholesterol-lowering agents and have other anti-atherogenic actions. We tested the effects of four different statins (fluvastatin, atorvastatin, simvastatin, and lovastatin) on ABCA1 expression in macrophages in vitro. The statins suppressed ABCA1 mRNA expression in RAW246.7 and THP-1 macrophage cell lines and in mouse peritoneal macrophages. The effect was time- and dose-dependent and was abolished by the addition of the post-reductase product, mevalonate. These findings imply that there is a possible modulation of the well-known beneficial effects of the statins on the reverse cholesterol transport pathway.
ATP结合盒转运蛋白A1(ABCA1)在细胞胆固醇流出中起关键作用,并有助于防止巨噬细胞变成泡沫细胞。他汀类药物被广泛用作降胆固醇药物,且具有其他抗动脉粥样硬化作用。我们在体外测试了四种不同的他汀类药物(氟伐他汀、阿托伐他汀、辛伐他汀和洛伐他汀)对巨噬细胞中ABCA1表达的影响。这些他汀类药物抑制了RAW246.7和THP-1巨噬细胞系以及小鼠腹腔巨噬细胞中ABCA1 mRNA的表达。这种作用具有时间和剂量依赖性,并且通过添加还原酶产物甲羟戊酸而被消除。这些发现表明,他汀类药物对胆固醇逆向转运途径的众所周知的有益作用可能存在调节。